Premium
P1‐392: DRUG DEVELOPMENT FOR AGITATION AND AGGRESSION IN ALZHEIMER'S DISEASE (AD): STUDY DESIGN AND OUTCOME MEASURES IN PHASE 2 STUDY OF SCYLLO‐INOSITOL (ELND005 STUDY AG201)
Author(s) -
Abushakra Susan R.,
Kesslak Patrick,
Kurth Matthias,
Fan Frank,
Bairu Menghis,
Miller David S.,
Lyketsos Constantine
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.634
Subject(s) - aggression , psychiatry , placebo , medicine , clinical global impression , psychomotor agitation , psychology , clinical psychology , pathology , alternative medicine